首页|miR-155与2型糖尿病患者骨质疏松关系的研究进展

miR-155与2型糖尿病患者骨质疏松关系的研究进展

扫码查看
2型糖尿病初期骨代谢的生化指标可发生改变,患者骨质疏松及骨折的风险较正常人群明显增加。骨质疏松症是一种全身性的骨骼疾病,以低骨量和骨组织微结构退化为特点,会导致骨脆性以及骨折易感性增加。2型糖尿病的主要发生机制为胰岛素抵抗,大量临床研究表明,胰岛素抵抗与骨质疏松之间存在关联。微小RNA(miRNA)中的miR-155与胰岛素抵抗之间存在密切关联。目前有研究发现miR-155表达增加可改善胰岛素敏感性,而胰岛素抵抗是导致糖尿病性骨质疏松症的潜在机制。然而2型糖尿病患者虽然骨质疏松或骨折风险增加,但其骨密度值却仍正常甚至稍增高,故而,目前仅通过骨密度尚不能完全解释2型糖尿病发生骨质疏松性骨折的相关机制。本文主要综述miR-155与2型糖尿病患者骨质疏松关系的进展。
Research progress on the relationship between miR-155 and osteoporosis in type 2 diabetes patients
Biochemical indicators of bone metabolism may change at the initial stage of type 2 diabetes,and the risk of osteoporosis and fracture in patients is significantly increased compared with normal people.Osteoporosis is a systemic bone disease characterized by low bone mass and degeneration of bone tissue microstructure,leading to increased bone fragility and susceptibility to fractures.The main mechanism of type 2 diabetes is insulin resistance(IR).A large number of clinical studies have shown that there is a relationship between insulin resistance and osteoporosis.There is a close association between miR-155 in microRNAs(miRNAs)and IR.At present,studies have found that the increased expression of miR-155 can improve insulin sensitivity,and IR is a potential mechanism leading to diabetes induced osteoporosis.However,although the risk of osteoporosis or fracture in type 2 diabetes patients increases,their bone mineral density(BMD)values are still normal or even slightly increased.Therefore,at present,the relevant mechanism of osteoporosis fracture in type 2 diabetes cannot be fully explained by BMD alone.This article mainly reviews the progress of the relationship between miR-155 and osteoporosis in type 2 diabetes patients.

Diabetes mellitus,type 2OsteoporosismiR-155

段思涵、刘红、文章新

展开 >

吉首大学医学院,吉首 416099

中南大学湘雅医学院附属株洲医院代谢内分泌科,株洲 412007

糖尿病,2型 骨质疏松 miR-155

湖南省自然科学基金

2022JJ790172

2024

中国医师杂志
中华医学会 湖南省医学会

中国医师杂志

CSTPCD
影响因子:0.876
ISSN:1008-1372
年,卷(期):2024.26(8)